CAR_Recap_Opioid_Settlement_-_Mallinckrodt__McKinsey__Endo.docx

CITY OF BUCKEYE 
                                                              Finance Department 
     
 
530 E Monroe Ave. • Buckeye, Arizona 85326 
Phone 623-349-6165 • www.buckeyeaz.gov 
 
National Opioid Settlement with Mallinckrodt, McKinsey, and Endo Public Defendants - Summary Recap 
Project Description:   
 
State and local governments across the country have been litigating against the opioid industry, alleging 
that the industry utilized unethical and illegal practices with respect to promoting the use of opioids.  
 
In December 2020, Council approved the One Arizona Opioid Settlement Memorandum of 
Understanding (MOU) between the State and Participating Local Governments. The MOU served to 
jointly approach settlement negotiations with the Pharmaceutical Supply Chain Participants. In 
November 2021, Council approved the One Arizona Opioid Agreement, which establishes Arizona’s 
disbursement of the funds related to a national class action lawsuit against opioid manufacturers and 
distributors. In December 2022, Council approved the execution and delivery of the National Opioids 
Distributor Settlement Agreement with three opioid distributors, McKesson, AmerisourceBergen, and 
Cardinal, and the Janssen Settlement Agreement with one manufacturer, Johnson & Johnson. In April 
2023, Council approved the execution and delivery of the National Opioids Distributor and Settlement 
Agreements in the National Settlement(s) for five opioid distributors: Teva, Allergan, Walmart, 
Walgreens, and CVS. In August 2025 Council approved the execution and delivery of the Purdue Direct 
Settlement. In August 2025, a new proposed national opioids settlement was reached with eight opioid 
manufacturers: Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus. The settlement is 
known as the Secondary Manufacturers Settlement.  
 
The Mallinckrodt, McKinsey, and Endo Public Defendants were included in the One Arizona Opioid 
Settlement Memorandum of Understanding (MOU) between the State and Participating Local 
Governments, which Council approved in December of 2020. Council to ratify the submission of the 
settlement participation forms for these defendants. The agreement provides for a complete waiver of 
any and all past, current, and future claims related to opioid use and is essentially a contract of 
adhesion, as there is no ability to negotiate the terms at the city level, as the State took on that 
responsibility. 
 
To receive these critically needed funds to assist in addressing the opioid crisis in our community, the 
staff recommends council ratify the signature on the Settlement Participation Form authorizing the city 
to participate in the opioid settlement. 
Settlement Award 
 
It is unknown how much the city will receive. 
Plans Once Grant Expires:  
 
Buckeye will continue to receive payments until the settlement is completed. 
Objectives and Expected Outcomes  
 
Funds received from these settlements will be used for personnel costs, treatment, prevention efforts, 
and education in the Buckeye community related to the opioid crisis.

Time Period for the Grant 
 
FY 2026 and ongoing until settlements are satisfied.